Bosentan
An endothelin receptor antagonist used to treat pulmonary arterial hypertension by relaxing and widening the blood vessels in the lungs. It blocks the action of endothelin, a potent substance that causes blood vessel constriction. It requires regular liver function monitoring and is teratogenic, requiring strict pregnancy prevention.
Moleküler Ağırlık
551,6000 g/mol
LogP
3,80
TPSA
154,00 Ų
Lipinski RO5
Başarısız
Terapötik Alanlar
Etki Mekanizması
Competitively binds to its target receptor without activating it, blocking the natural ligand from binding and preventing receptor-mediated signaling.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Competitively binds to its target receptor without activating it, blocking the natural ligand from binding and preventing receptor-mediated signaling.
2D Yapı
Cite this structure
Embed this structure
SMILES
COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO
InChI
InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)
Molecular Formula
C27H29N5O6S
HBD / HBA
2 / 11
Döndürülebilir Bağlar
11
Ağır Atomlar
39
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
An endothelin receptor antagonist used to treat pulmonary arterial hypertension by relaxing and widening the blood vessels in the lungs. It blocks the action of endothelin, a potent substance that causes blood vessel constriction. It requires regular liver function monitoring and is teratogenic, requiring strict pregnancy prevention.
Competitively binds to its target receptor without activating it, blocking the natural ligand from binding and preventing receptor-mediated signaling.
Yes, Bosentan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL957. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 104865. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="bosentan"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/bosentan/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/bosentan/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/bosentan/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="bosentan"></drugfyi-drug>